AURA BIOSCIENCES, INC. AURA 深 滬
等待開盤 09-25 09:30:00 美东时间
6.17
-0.050
-0.80%
華盛通- 最 高6.38
- 今 開6.24
- 成交量 11.46万股
- 最 低 6.02
- 昨 收 6.22
- 總市值 3.83亿
- 52周最高 12.3782
- 市盈率 靜 --
- 換手率 0.18%
- 52周最低 4.345
- 委 比 -97.07%
- 總股本 6211.99万
- 歷史最高 26.16
- 量 比 0.21
- 振 幅 5.79%
- 歷史最低 4.345
- 每 手 1
- 風險率 0.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Advancing Cancer Research Brings New Hope for Patients Worldwide
NetworkNewsWire Editorial Coverage NEW YORK, Sept. 17, 2025 /PRNewswire/ -- Progress in RNA-based medicines, immunotherapies and targeted treatments is not simply desirable, it is a critical...
09-17 20:30
7点！医械早播报-9/17
（来源：医疗器械创新网） 01 监管政策与招投标 上海发布高端医疗器械产业全链条发展行动方案 2025 年 9 月 4 日印发，目标 2027 年新增境内三类医...
09-17 07:00
4年、刷新中位OS纪录，奥希替尼与阿斯利康开启肺癌长生存新篇章
（来源：氨基观察） 每年9月，全球肺癌领域的目光都会聚焦于同一盛会——世界肺癌大会（WCLC）。如何从更多免疫、靶向联合治疗策略中，进一步提升疗效和生存获益是...
09-15 18:44
OS为尺，衡量肿瘤药真章：4年OS，阿斯利康如何脱颖而出？
（来源：药剂Talks） 近期，FDA发布了《肿瘤临床试验中总生存期评估方法指南草案》，首次系统明确总生存期（OS）在随机对照试验中的核心地位及其具体操作规范...
09-13 09:01
百利天恒iza-bren双抗ADC获WCLC双重认可，恒生医疗ETF(513060交投活跃成交额已达18亿元，港股创新药精选ETF(520690)红盘震荡
截至2025年9月9日13:01，恒生医疗保健指数下跌0.32%。成分股方面涨跌互现，阿里健康领涨7.09%，巨子生物上涨6.96%，乐普生物-B上...
09-09 13:17
全球肺癌大会2025新药生存期数据领跑，AZ、默沙东、复宏汉霖谁与争锋
（来源：医趋势） 在9月6日揭幕的2025年世界肺癌大会（WCLC）上，下一代免疫、下一代ADC药物展现出的优异疗效或将颠覆肺癌治疗格局。 全球顶级药企在实现...
09-09 11:06
AstraZeneca Lung Cancer Combo Extends Patient Survival By Years In Key Study
AstraZeneca's Tagrisso with chemotherapy improved survival in advanced NSCLC, extending median overall survival by nearly 10 months over monotherapy.
09-09 01:44
Aura Minerals to Delist From Toronto Exchange, Consolidate Trading on Nasdaq
Aura Minerals Inc. (NASDAQ:AUGO) (TSX:ORA) (B3: AURA33) ("Aura" or the "Company") today announced that its application for a voluntary delisting (the "Delisting") of its common shares (each a "Common Share") from the
09-08 18:10
Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
On September 3, 2025, Aura Biosciences, Inc. announced that its CEO, Elisabet de los Pinos, PhD, will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025, at 11:00 a.m. ET. The live webcast will be available on the "Investors & Media" page of the Company’s website, with a replay archived for 90 days. Aura Biosciences is a clinical-stage biotech company developing precision therapies for solid tumors to pr...
09-03 11:00
Payment of dividends to BDR holders
Aura Minerals Inc. announced a dividend of US$0.11 per BDR, converted at a rate of BRL 5.4134 per USD, with a 0.38% transaction tax, resulting in R$0.5932 per BDR, payable by September 5, 2025. The company, focused on 360° Mining, operates gold and base metal projects across the Americas, including mines in Honduras, Brazil, Mexico, and projects in Guatemala and Colombia.
08-29 23:37
